Jessina McGregor

Professor
mcgregoj@ohsu.edu

Office: 503-494-4722

Credentials: 
Ph.D. in Epidemiology, University of Maryland, Baltimore, 2005 B.S. in Microbiology, Oregon State University, 2001 B.A. in International Studies, Oregon State University, 2001

Profile Field Tabs

At OSU
Affiliated with: 
Pharmacy Professnl Instr
Headquarters: 
Portland - OHSU
Faculty Type: 
Pharmacy Practice
Career Links: 
Research Group
Research/Career Interests: 

Jessina McGregor’s research interests include antibiotic utilization, infectious diseases, medical informatics, epidemiologic methods, and risk adjustment.

Selected Publications

McGregor JC, Dumyati G, Casiano-Colón AE, Chang P, Klevens RM. Usefulness of Antibiogram Surveillance for Methicillin-Resistant Staphylococcus aureus in Outpatient Pediatric Populations. Diagn Microbiol Infect Dis.  May 2009; 64(1):78-83.

Perencevich EN, McGregor JC, Shardell M, Furuno JP, Harris AD, Morris JG, Fisman DN, Johnson JA. Summer Peaks in Gram-Negative Bacterial Infections among Hospitalized Patients. Infect Control Hosp Epidemiol. Dec 2008; 29(12): 1124-1131.

McGregor JC, Allen GP, Bearden DT. Levofloxacin in the treatment of complicated urinary tract infections and acute pyelonephritis. Ther Clin Risk Manag. Oct 2008; 4(5): 843-853.

McGregor JC, Rich SA, Harris AD, Perencevich EN, Osih R, Lodise Jr. TP, Miller RR, Furuno JP. A Systematic Review of the Methods Used to Assess the Association Between Appropriate Antibiotic Therapy and Mortality in Bacteremic Patients. Clin Infect Dis. August 1, 2007; 45(3): 329-37.

McGregor JC, Harris AD, Furuno JP, Bradham DD, Perencevich EN.  Relative Influence of Antibiotic Therapy Attributes on Physician Choice in Treating Acute Uncomplicated Pyelonephritis. Med Decis Making. July/August 2007; 27(4): 387-394.

Osih R, McGregor JC, Rich SE, Moore AC, Furuno JP, Perencevich EN, Harris AD. Impact of Empiric Antibiotic Therapy on Outcomes in Patients with Pseudomonas aeruginosa Bacteremia. Antimicrob Agents Chemother. March 2007; 51(3): 839-844.

McGregor JC, Weekes E, Forrest GN, Standiford HC, Perencevich EN, Furuno JP, Harris AD.  Impact of a Computerized Clinical Decision Support System on Reducing Inappropriate Antimicrobial Use:  A Randomized Controlled Trial.  J Am Med Inform Assoc. July/August 2006; 13(4): 378-384.

McGregor JC, Perencevich EN, Furuno JP, Langenberg P, Flannery K, Zhu J, Fink JC, Bradham DD, Harris AD.  Comorbidity risk-adjustment measures were developed and validated for studies of antibiotic-resistant infections.  J Clin Epidemiol. December 2006; 59(12): 1266-1273.

McGregor JC, Weekes E, Forrest GN, Standiford HC, Perencevich EN, Furuno JP, Harris AD. Impact of a Computerized Clinical Decision Support System on Reducing Inappropriate Antimicrobial Use: A Randomized Controlled Trial. Journal of the American Medical Informatics Association. 2006;13(4):378-384.

Harris AD, McGregor JC, Furuno JP. What Infection Control Interventions Should Be Undertaken to Control Multidrug-Resistant Gram-Negative Bacteria? Clinical Infectious Disease. 2006;43(Suppl 2):S57-S61.

Furuno JP, McGregor JC, Harris AD, Johnson JA, Johnson JK, Langenberg P, Venezia RA, Finklestein J, Smith DL, Perencevich, EN. Identifying High-Risk Groups for Carriage of Antibiotic-Resistant Bacteria. Archives of Internal Medicine. 2006;166:580-585.

Harris AD, McGregor JC, Perencevich EN, Furuno JP, Zhu J, Peterson D, Finklestein J. The Use and Interpretation of Quasi-Experimental Studies in Medical Informatics. Journal of the American Medical Informatics Association. 2006;13(1):16-23.

Furuno JP, Perencevich EN, Johnson JA, Wright MO, McGregor JC, Morris Jr., JG, Nemoy LL, Roghmann MC, Standiford HC, Hebden JN, Strauss SM, Harris AD. Methicillin-resistant Staphylococcus aureus and Vancomycin-resistant Enterococci Co-colonization. Emerging Infectious Diseases. 2005;11(10):1539-44.

McGregor JC, Kim PW, Perencevich EN, Bradham DD, Furuno JP, Kaye KS, Fink JC, Langenberg P, Roghmann MC, Harris AD. The Utility of the Chronic Disease Score and Charlson Comorbidity Index as Comorbidity Measures for use in Epidemiologic Studies of Antibiotic-Resistant Organisms. American Journal of Epidemiology. 2005;161(5):483-93.